Prof.Dr.med. ID: 63635

Victor-Felix Mautner

graph of relations

Publications

  1. 2018
  2. Dorsal root ganglia in vivo morphometry and perfusion in female patients with Fabry disease

    Godel, T., Köhn, A., Muschol, N., Kronlage, M., Schwarz, D., Kollmer, J., Heiland, S., Bendszus, M., Mautner, V-F. & Bäumer, P., 11.2018, In: J NEUROL. 265, 11, p. 2723-2729 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas

    Kehrer-Sawatzki, H., Kluwe, L., Friedrich, R. E., Summerer, A., Schäfer, E., Wahlländer, U., Matthies, C., Gugel, I., Farschtschi, S., Hagel, C., Cooper, D. N. & Mautner, V-F., 07.2018, In: HUM GENET. 137, 6-7, p. 543-552 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1

    Sellmer, L., Farschtschi, S., Marangoni, M., Heran, M. K. S., Birch, P., Wenzel, R., Mautner, V-F. & Friedman, J. M., 23.04.2018, In: ORPHANET J RARE DIS. 13, p. 62

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Dorsal root ganglia volume differentiates schwannomatosis and neurofibromatosis 2

    Godel, T., Mautner, V-F., Farschtschi, S., Pham, M., Schwarz, D., Kronlage, M., Gugel, I., Heiland, S., Bendszus, M. & Bäumer, P., 04.2018, In: ANN NEUROL. 83, 4, p. 854-857 4 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Neuropathies in the setting of Neurofibromatosis tumor syndromes: Complexities and opportunities

    Schulz, A., Grafe, P., Hagel, C., Bäumer, P., Morrison, H., Mautner, V-F. & Farschtschi, S., 01.01.2018, In: EXP NEUROL. 299, Pt B, p. 334-344 11 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  7. Cerebrovascular Insult as Presenting Symptom of Neurofibromatosis Type 2 in Children, Adolescents, and Young Adults

    Gugel, I., Mautner, V-F., Kluwe, L., Tatagiba, M. S. & Schuhmann, M. U., 2018, In: FRONT NEUROL. 9, p. 733

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. 2017
  9. Human dorsal root ganglion in vivo morphometry and perfusion in Fabry painful neuropathy

    Godel, T., Bäumer, P., Pham, M., Köhn, A., Muschol, N., Kronlage, M., Kollmer, J., Heiland, S., Bendszus, M. & Mautner, V-F., 19.09.2017, In: NEUROLOGY. 89, 12, p. 1274-1282 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells

    Fischer-Huchzermeyer, S., Dombrowski, A., Hagel, C., Mautner, V. F., Schittenhelm, J. & Harder, A., 01.07.2017, In: AM J PATHOL. 187, 7, p. 1623-1632

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Muscle action potential scans and ultrasound imaging in neurofibromatosis type 2

    Farschtschi, S., Gelderblom, M., Buschbaum, S., Bostock, H., Grafe, P. & Mautner, V. F., 03.2017, In: MUSCLE NERVE. 55, 3, p. 350-358

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Non-optic glioma in adults and children with neurofibromatosis 1

    Sellmer, L., Farschtschi, S., Marangoni, M., Heran, M. K. S., Birch, P., Wenzel, R., Friedman, J. M. & Mautner, V-F., 15.02.2017, In: ORPHANET J RARE DIS. 12, 1, p. 34

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis

    Kehrer-Sawatzki, H., Farschtschi, S., Mautner, V-F. & Cooper, D. N., 02.2017, In: HUM GENET. 136, 2, p. 129-148

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Therapie und Verlauf neurologischer Erkrankungen: Kapitel H7: Neurokutane Syndrome

    Farschtschi, S. C., Tatagiba, M. & Mautner, V-F., 2017, Therapie und Verlauf neurologischer Erkrankungen. Diener, H-C., Gerloff, C. & Dieterich, M. (eds.). 7 ed. Stuttgart: Kohlhammer, p. 997 - 1006 10 p.

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesEducationpeer-review

  15. 2016
  16. The putative oncogene CPI-17 is up-regulated in schwannoma

    Hagel, C., Dornblut, C., Schulz, A., Wiehl, U., Friedrich, R. E., Huckhagel, T., Mautner, V-F. & Morrison, H., 12.2016, In: NEUROPATH APPL NEURO. 42, 7, p. 664-668

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Muskelaktionspotenzial-Scan und Ultraschall zur Erfassung der Neuropathie bei der Neurofibromatose Typ 2

    Farschtschi, S. C., Gelderblom, M., Buschbaum, S., Bostock, H., Grafe, P. & Mautner, V-F., 19.11.2016, 20. Tagung der Arbeitsgemeinschaft Neurofibromatose.

    Research output: SCORING: Contribution to book/anthologyConference contribution - PosterResearch

  18. Multifocal Nerve Lesions and LZTR1 Germline Mutations in Segmental Schwannomatosis

    Farschtschi, S., Mautner, V-F., Pham, M., Nguyen, R., Kehrer-Sawatzki, H., Hutter, S., Friedrich, R. E., Schulz, A., Morrison, H., Jones, D. T. W., Bendszus, M. & Bäumer, P., 10.2016, In: ANN NEUROL. 80, 4, p. 625-8

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. Effector T cell subclasses associate with tumor burden in neurofibromatosis type 1 patients

    Farschtschi, S., Park, S-J., Sawitzki, B., Oh, S-J., Kluwe, L., Mautner, V. F. & Kurtz, A., 09.2016, In: CANCER IMMUNOL IMMUN. 65, 9, p. 1113-1121

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis

    Ahlawat, S., Fayad, L. M., Khan, M. S., Bredella, M. A., Harris, G. J., Evans, D. G., Farschtschi, S., Jacobs, M. A., Chhabra, A., Salamon, J. M., Wenzel, R., Mautner, V. F., Dombi, E., Cai, W., Plotkin, S. R., Blakeley, J. O. & Whole Body MRI Committee for the REiNS International Collaboration, 16.08.2016, In: NEUROLOGY. 87, 7 Suppl 1, p. S31-9

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2

    Farschtschi, S., Merker, V. L., Wolf, D., Schuhmann, M., Blakeley, J., Plotkin, S. R., Hagel, C. & Mautner, V. F., 06.2016, In: ACTA NEUROL SCAND. 133, 6, p. 475-480

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. The importance of nerve microenvironment for schwannoma development

    Schulz, A., Büttner, R., Hagel, C., Baader, S. L., Kluwe, L., Salamon, J., Mautner, V-F., Mindos, T., Parkinson, D. B., Gehlhausen, J. R., Clapp, D. W. & Morrison, H., 28.05.2016, In: ACTA NEUROPATHOL. 132, 2, p. 289-307

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Recurrent Multilocular Mandibular Giant Cell Granuloma in Neurofibromatosis Type 1: Evidence for Second Hit Mutation of NF1 Gene in the Jaw Lesion and Treatment with Curettage and Bone Substitute Materials

    Friedrich, R., Grob, T., Hollants, S., Zustin, J., Spaepen, M., Mautner, V-F., Lübke, A., Hagel, C., Legius, E. & Brems, H., 15.05.2016, In: J CRANIO MAXILL SURG. 44, 8, p. 1054-1060

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patients

    Hutter, S., Piro, R. M., Waszak, S. M., Kehrer-Sawatzki, H., Friedrich, R. E., Lassaletta, A., Witt, O., Korbel, J. O., Lichter, P., Schuhmann, M. U., Pfister, S. M., Tabori, U., Mautner, V. F. & Jones, D. T. W., 05.2016, In: HUM GENET. 135, 5, p. 469-75 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Schwannomatose

    Mautner, V-F. & Farschtschi, S. C., 2016, Ratgeber Schwannomatose: Schwannomatose. 1 ed. Hamburg: Bundesverband Neurofibromatose e.V., 27 p.

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesEducation

  26. 2015
  27. Unilateral gynaecomastia in a 16-month-old boy with neurofibromatosis type 1 - case report and brief review of the literature

    Friedrich, R. E., Hagel, C. & Mautner, V-F., 03.12.2015, In: GMS INTERDISCIP PLAS. 4, p. Doc11

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Nerve Sheath Tumors in Neurofibromatosis Type 1: Hannover Med Sch, Dept Nucl Med, Hannover, Germany

    Salamon, J., Papp, L., Tóth, Z., Laqmani, A., Apostolova, I., Adam, G., Mautner, V. F. & Derlin, T., 01.12.2015, In: PLOS ONE. 10, 12, p. e0143305

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Ipsilateral Sphenoid Wing Dysplasia, Orbital Plexiform Neurofibroma and Fronto-Parietal Dermal Cylindroma in a Patient with Segmental Neurofibromatosis

    Friedrich, R. E., Hagel, C. & Mautner, V-F., 12.2015, In: ANTICANCER RES. 35, 12, p. 6813-8 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors

    Salamon, J., Mautner, V. F., Adam, G. & Derlin, T., 12.2015, In: ROFO-FORTSCHR RONTG. 187, 12, p. 1084-1092 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Reduced dosage of bevacizumab in treatment of vestibular schwannomas in patients with neurofibromatosis type 2

    Farschtschi, S., Kollmann, P., Dalchow, C., Stein, A. & Mautner, V-F., 12.2015, In: EUR ARCH OTO-RHINO-L. 272, 12, p. 3857-60 4 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Cerebral glucose metabolism in adults with neurofibromatosis type 1

    Apostolova, I., Derlin, T., Salamon, J., Amthauer, H., Granström, S., Brenner, W., Mautner, V-F. & Buchert, R., 02.11.2015, In: BRAIN RES. 1625, p. 97-101 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. Impairment of Procedural Learning and Motor Intracortical Inhibition in Neurofibromatosis Type 1 Patients

    Zimerman, M., Wessel, M. J., Timmermann, J. E., Granström, S., Gerloff, C., Mautner, V-F. & Hummel, F., 01.09.2015, In: EBIOMEDICINE. 2, 10, p. 1430-1437

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Foreign Body Abscess Mimicking a Malignant Peripheral Nerve Sheath Tumor in a Patient With Neurofibromatosis Type 1

    Salamon, J., Hagel, C., Friedrich, R. E., Mautner, V-F. & Derlin, T., 08.2015, In: CLIN NUCL MED. 40, 8, p. 674-675

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Perfusion single photon emission computed tomography in a mouse model of neurofibromatosis type 1: towards a biomarker of neurologic deficits

    Apostolova, I., Niedzielska, D., Derlin, T., Koziolek, E. J., Amthauer, H., Salmen, B., Pahnke, J., Brenner, W., Mautner, V. F. & Buchert, R., 08.2015, In: J CEREBR BLOOD F MET. 35, 8, p. 1304-12 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. Quantitative associations of scalp and body subcutaneous neurofibromas with internal plexiform tumors in neurofibromatosis 1

    Jett, K., Nguyen, R., Arman, D., Birch, P., Chohan, H., Farschtschi, S., Fuensterer, C., Kluwe, L., Friedman, J. M. & Mautner, V. F., 07.2015, In: AM J MED GENET A. 167, 7, p. 1518-24 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. Growth in neurofibromatosis 1 microdeletion patients

    Ning, X., Farschtschi, S., Jones, A., Kehrer-Sawatzki, H., Mautner, V-F. & Friedman, J. M., 26.06.2015, In: CLIN GENET. 89, 3, p. 351-354

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. Determination of the mutant allele frequency in patients with neurofibromatosis type 2 and somatic mosaicism by means of deep sequencing

    Spyra, M., Otto, B., Schön, G., Kehrer-Sawatzki, H. & Mautner, V-F., 29.05.2015, In: GENE CHROMOSOME CANC. 54, 8, p. 482-488

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Preclinical assessment of the anticancer drug response of plexiform neurofibroma tissue using primary cultures

    Wei, J., Mautner, V. F., Friedrich, R. E. & Kluwe, L., 04.2015, In: J CLIN NEUROL. 11, 2, p. 172-7 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. Keratinocytic epidermal nevus syndrome with Schwann cell proliferation, lipomatous tumour and mosaic KRAS mutation

    Farschtschi, S., Mautner, V-F., Hollants, S., Hagel, C., Spaepen, M., Schulte, C., Legius, E. & Brems, H., 01.01.2015, In: BMC MED GENET. 16, 1, p. 6

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Faszikuläre Mikroläsionen und Neuropathie bei der Schwannomatose

    Farschtschi, S. C., Bäumer, P., Anna-Lena, H., Hauck, M., Gelderblom, M., Peter, G., Pham, M. & Mautner, V-F., 2015, 88. Kongress der Deutschen Gesellschaft für Neurologie mit Fortbildungsakademie.

    Research output: SCORING: Contribution to book/anthologyConference contribution - PosterResearch

  42. Impact of ADHD in Adults With Neurofibromatosis Type 1: Associated Psychological and Social Problems.

    Mautner, V. F., Granström, S. & Leark, R. A., 2015, In: J ATTEN DISORD. 19, 1, p. 35-43

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Multiple Parameter der Nervenerregbarkeit bei der NF2

    Peter, G., Farschtschi, S. C., Bostock, H. & Mautner, V-F., 2015, 88. Kongress der Deutschen Gesellschaft für Neurologie mit Fortbildungsakademie.

    Research output: SCORING: Contribution to book/anthologyConference contribution - PosterResearch

  44. 2014
  45. Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variants

    Hutter, S., Piro, R. M., Reuss, D. E., Hovestadt, V., Sahm, F., Farschtschi, S., Kehrer-Sawatzki, H., Wolf, S., Lichter, P., von Deimling, A., Schuhmann, M. U., Pfister, S. M., Jones, D. T. W. & Mautner, V. F., 01.09.2014, In: ACTA NEUROPATHOL. 128, 3, p. 449-52 4 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  46. Influence of learning disabilities on the tumour predisposition syndrome NF1--survey from adult patients' perspective

    Granström, S., Friedrich, R. E., Langenbruch, A. K., Augustin, M. & Mautner, V-F., 01.07.2014, In: ANTICANCER RES. 34, 7, p. 3675-81 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms

    Reuss, D. E., Habel, A., Hagenlocher, C., Mucha, J., Ackermann, U., Tessmer, C., Meyer, J., Capper, D., Moldenhauer, G., Mautner, V-F., Frappart, P-O., Schittenhelm, J., Hartmann, C., Hagel, C., Katenkamp, K., Petersen, I., Mechtersheimer, G. & von Deimling, A., 01.04.2014, In: ACTA NEUROPATHOL. 127, 4, p. 565-72 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. 18F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off

    Salamon, J., Veldhoen, S., Apostolova, I., Bannas, P., Yamamura, J., Herrmann, J., Friedrich, R. E., Adam, G., Mautner, V-F. & Derlin, T., 01.02.2014, In: EUR RADIOL. 24, 2, p. 405-12 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. Analysis of crossover breakpoints yields new insights into the nature of the gene conversion events associated with large NF1 deletions mediated by nonallelic homologous recombination

    Bengesser, K., Vogt, J., Mussotter, T., Mautner, V-F., Messiaen, L., Cooper, D. N. & Kehrer-Sawatzki, H., 01.02.2014, In: HUM MUTAT. 35, 2, p. 215-26 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. Neuronal merlin influences ERBB2 receptor expression on Schwann cells through neuregulin 1 type III signalling

    Schulz, A., Kyselyova, A., Baader, S. L., Jung, M. J., Zoch, A., Mautner, V-F., Hagel, C. & Morrison, H., 01.02.2014, In: BRAIN. 137, 2, p. 420-32 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. Syndromale abdominale Ganglioneurome: eine seltene Ursache falsch-positiver Befunde in der F-18-FDG PET/CT bei Neurofibromatose Typ 1

    Derlin, T., Hagel, C. & Mautner, V. F., 09.01.2014, In: ROFO-FORTSCHR RONTG. 186, 7, p. 706-707

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. Efficacy and selectivity of nilotinib on NF1-associated tumors in vitro

    Wei, J., Schnabel, C., Spyra, M., Mautner, V-F., Friedrich, R. E., Hagel, C., Manley, P. W. & Kluwe, L., 01.01.2014, In: J NEURO-ONCOL. 116, 2, p. 231-6 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo

    Wei, J., Freytag, M., Schober, Y., Nockher, W. A., Mautner, V-F., Friedrich, R. E., Manley, P. W., Kluwe, L. & Kurtz, A., 01.01.2014, In: PLOS ONE. 9, 10, p. e107760

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  54. Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1

    Nguyen, R., Jett, K., Harris, G. J., Cai, W., Friedman, J. M. & Mautner, V-F., 2014, In: J NEURO-ONCOL. 116, 2, p. 307-313 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  55. Neurokutane Erkrankungen

    Panteliadis, C. P., Hagel, C., Mautner, V-F., Friedrich, R. & Rosenbaum, T., 2014, Neuropädiatrie - Evidenzbasierte Therapie. 2 ed. Elsevier, 27 p.

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesEducation